Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

Cutaneous Venous Malformations: early-phase trial registry

1 of 1 indexed Cutaneous Venous Malformations trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

Cutaneous Venous Malformations: 1 US clinical trial tracked, 1 recruiting.

Cutaneous Venous Malformations is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Palvella Therapeutics, running 1 of these trials.

Enrollment posture brief

Registry condition cutaneous-venous-malformations

OPEN 1 | RECR 100% | LATE 0 | EARLY 1 | RANK #11370 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Cutaneous Venous Malform (th…100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Cutaneous Venous Malformations

Cutaneous Venous Malformations lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Cutaneous Venous Malformations on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Cutaneous Venous Malformations is recruiting above its size-band peers.

    1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 21

Phase Distribution

PhaseTrial count
Phase 2 1

Top Sponsors

Named interventions

Most-linked intervention names on Cutaneous Venous Malformations records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

QTORIN 3.9% rapamycin anhydrous gel Drug
1 trials

US sites by state

Facility locations filed on Cutaneous Venous Malformations trials. A trial with sites in several states counts in each.

Utah 1 trials
Pennsylvania 1 trials
Ohio 1 trials
North Carolina 1 trials
Minnesota 1 trials
Maryland 1 trials
Colorado 1 trials
California 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Cutaneous Venous Malformations page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Cutaneous Venous Malformations trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Palvella Therapeutics sponsors the most Cutaneous Venous Malformations trials on record, review their full trial history before evaluating a specific study. See Palvella Therapeutics's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Cutaneous Venous Malformations condition card totals 1 registered trials; most-linked intervention QTORIN 3.9% rapamycin anhydrous gel; top US site state Utah. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.